'Study schema' presentation slideshows

Presented By Martin Schlumberger at 2014 ASCO Annual Meeting

A phase 3, multicenter, randomized, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer (SELECT). Presented By Martin Schlumberger at 2014 ASCO Annual Meeting. Disclosures.

503 views • 17 slides

Inhibition of Poly (ADP-Ribose) Polymerase (PARP) by ABT-888 in Patients With Advanced Malignancies: Results of a Phase

247 views • 16 slides

394 views • 13 slides

Fowler NH et al. Proc ASH 2011;Abstract 99.

Phase II Study with R-FND Followed by 90-Y Ibritumomab Tiuxetan Radioimmunotherapy and Rituximab Maintenance for Untreated High-Risk Follicular Lymphoma. Fowler NH et al. Proc ASH 2011;Abstract 99. Study Schema. Induction (N = 47). Consolidation (n = 38). Maintenance (n = 39*).

250 views • 8 slides

Trial Design in BRIDG EA Diagrams presented to Stage II Meeting

51 views • 5 slides